Le X, Sakai H, Felip E, Veillon R, et al. Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice. Clin Cancer Res 2022;28:1117-1126.
PMID: 34789481